Altoida is a commercial-stage digital health company headquartered in Washington, D.C., that uses advanced neuroscience, machine learning, and augmented reality to evaluate neurological health.
Subscribe to see Altoida’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Altoida is a healthtech company headquartered in United States. Xcout tracks 9 named people at Altoida, including Marc Jones (Executive Chairman and Chief Executive Officer). Xcout recorded 1 job posting from Altoida in the last 90 days.
3 more named people on record for Altoida, with roles, board committees and tenure — see the full roster →
Xcout recorded 1 job posting from Altoida in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Altoida's hiring signals →
A few of Altoida's closest competitors — see the full list of competitors and alternatives →
Virtuleap is a leader in cognitive therapeutics and diagnostics that combines neuroscience, virtual reality, and artificial intelligence, with its headquarters located in Lisbon, Portugal.
Neurotrack Technologies, Inc. is a small business utilizing NIA funding to develop digital cognitive screening tools to help providers assess for mild cognitive impairment and dementia.
BrainCheck, Inc. is a digital cognitive assessment and care planning company headquartered in Austin, Texas, that offers a mobile interactive test and related healthcare services.
Neuro-Vascular Research & Design Corp develops artificial intelligence-powered intraoperative neuromonitoring (IONM) platforms and precision hardware for surgical environments. The company's technology provides real-time data analysis to help healthcare providers detect neurological risks and guide surgical decision-making during high-risk surgeries.
Basil Health is a neuro-wellness technology company building platforms that track stress, focus, calm, and sleep. It combines insights from ancient wisdom, modern neuroscience, and AI-driven EEG biofeedback.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.